Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper

ECCO · 2023 · Europe

Source and licence

Authors
Roger Feakins, Paula Borralho Nunes, Ann Driessen et al.
Title
Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper
Journal
Journal of Crohn's & Colitis, 2023
Licence
CC BY 4.0
Changes
Verbatim excerpts; formatting adapted

Full text retrieved 2026-10-27 from Europe PMC · PMC10896637

Licence statement of the original publication

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.

Open the original publication →Full text on Europe PMC

Recommendations

We found no explicitly labelled recommendations in this publication; its recommendations are in the running text of the original.

Abstract

Histological assessment of endoscopic biopsies in inflammatory bowel disease [IBD] plays an important role in clinical management, investigative studies, and clinical trials. Scoring schemes consisting of multiple histological items and offering considerable precision are widely available. However, definitions of histological abnormalities are often inconsistent. Furthermore, interobserver variability for their recognition and assessment may be high.

The European Crohn’s and Colitis Organisation [ECCO] formed an expert panel to explore definitions of histological abnormalities in IBD, with the aim of improving the quality of diagnosis and facilitating development of scoring schemes. The process confirmed that the current definitions often have no evidence base and vary between sources. Using available evidence and expert knowledge, the panel produced a series of ECCO consensus position statements on histological features in IBD.

Contents of the original publication

The section headings of the original.

  • 1. Introduction
  • 2. Materials and Methods
  • 3. ECCO Positions
  • 3.1. Architecture
  • 3.2. Epithelium
  • 3.3. Chronic Inflammation
  • 3.4. Eosinophils
  • 3.5. Granulomas
  • 3.6. Acute inflammation
  • 3.8. Distribution of abnormalities
  • 3.9. Dysplasia
  • 4. Discussion

A question about this guideline?

Medelix answers clinical questions from guidelines and studies – every statement with its source.

Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint